Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
04/1999
04/28/1999EP0910573A1 New amino acid derivatives and their use as thrombin inhibitors
04/28/1999EP0910572A1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation
04/28/1999EP0910416A2 Radiopharmaceutical compositions capable of localizing at sites of thrombus
04/28/1999EP0784629B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases
04/28/1999EP0679092B1 Cytokine restraining agents
04/28/1999CN1215394A Micacocidin derivatives
04/24/1999CA2224066A1 Peptides as analgesics
04/24/1999CA2219437A1 Peptides as analgesics
04/22/1999WO1999019352A2 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids
04/22/1999WO1999019347A1 Synthetic genes with immunomodulatory effects
04/22/1999WO1999019346A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin
04/22/1999WO1999019294A1 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
04/22/1999WO1999018856A1 Novel fluorescent reporter molecules and their applications including assays for caspases
04/22/1999WO1999018781A1 Dipeptide apoptosis inhibitors and the use thereof
04/22/1999WO1999002565A3 Agent for the treatment and/or prophylaxis of microcirculation disorders
04/22/1999WO1999002146A8 Amino acid derivatives
04/22/1999CA2308125A1 Novel fluorescent reporter molecules and their applications including assays for caspases
04/22/1999CA2306991A1 Ligand binding site of rage and uses thereof
04/22/1999CA2306823A1 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
04/21/1999EP0909822A1 Novel antitumor compounds and process for producing the same
04/21/1999EP0909176A1 Reactor and method for solid phase peptide synthesis
04/21/1999EP0765338B1 Arginine mimic derivatives as enzyme inhibitors
04/21/1999EP0717731B1 Difluoro statone antiviral analogs
04/21/1999EP0695184B1 Hiv protease inhibitors
04/21/1999CN1214691A Process for preparation of N-methyl-D-phenylalanyl-N-[1-[3-[(aminoiminomethyl)-amino] propyl]-3,3-difluoro-2-oxohexyl]-L-prolinamide
04/21/1999CN1214690A Specific immunophilin ligands as antiasthmatics and immunosuppressants
04/20/1999CA2250664A1 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
04/15/1999WO1999017791A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents
04/15/1999WO1999017790A1 PEPTIDE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS
04/15/1999WO1999017778A1 α-KETOAMIDE MULTICATALYTIC PROTEASE INHIBITORS
04/15/1999WO1999002153A9 Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases
04/15/1999WO1998049190A9 Substituted oxadiazole cysteine protease inhibitors
04/15/1999DE19745151A1 New N-2-Mercapto-3-phenyl-propionyl di:peptide derivatives
04/15/1999CA2305528A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents
04/15/1999CA2304116A1 Peptide-containing .alpha.-ketoamide cysteine and serine protease inhibitors
04/14/1999EP0907643A1 Compounds with growth hormone releasing properties
04/14/1999EP0907374A1 Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis
04/14/1999EP0759934B1 Neurotensin antagonist peptides
04/14/1999EP0621789B1 Pharmaceutical pentapeptide compositions and methods of use thereof
04/13/1999CA2110437C 15-deoxysperqualin analogs, their method of preparation and their use in therapeutics
04/08/1999WO1999016789A1 Apoptosis-related compounds and their use
04/08/1999WO1999016427A1 Active agent transport systems
04/08/1999CA2305681A1 Apoptosis-related compounds and their use
04/08/1999CA2304951A1 Active agent transport systems
04/07/1999EP0906334A1 Auto-deconvoluting combinatorial libraries
04/07/1999EP0906333A2 Substrates and inhibitors of proteolytic enzymes
04/07/1999EP0854716A4 Androgenic directed compositions
04/07/1999EP0697882A4 Use of glutathione diesters
04/07/1999EP0659181B1 Sulfonamide inhibitors of hiv-aspartyl protease
04/07/1999EP0556214B1 Process for amplifying hla class i nucleic acid
04/07/1999CN1213379A Peptide derivatives
04/06/1999US5892112 Acylation of amino acids with anhydrides or carboxy groups, amidation with amine and conversion of acid or ester to hydroxamic acid and hydrolysis
04/06/1999US5892052 Process for making retroviral protease inhibiting compounds
04/06/1999US5891994 Peptides and polypeptides which induce antibodies against hiv-1 tat proteins; for vaccines; diagnosis
04/06/1999US5891869 Basic oxazoline-amide derivatives of GE2270 and GE2270-like antibiotics
04/06/1999US5891852 Serine protease inhibitors-cycloheptane derivatives
04/06/1999US5891695 Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use
04/06/1999CA1340485C Peptide analogs and their use as haptens to elicit catalytic antibodies
04/01/1999WO1999015169A1 Thrombin inhibitors
04/01/1999WO1999015130A2 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
04/01/1999WO1999010373B1 Non-immunosuppressive cyclosporins and their use in the prevention and treatment of hiv infection
04/01/1999WO1999003878A3 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis
04/01/1999WO1998014592A3 Telomerase reverse transcriptase
04/01/1999DE19742844A1 New substituted imidazolidine-2,4-diones useful in preparation of enzyme inhibitors, especially protease inhibitors
04/01/1999CA2301614A1 Thrombin inhibitors
03/1999
03/31/1999EP0905246A1 Cloning of chicken anaemia DNA
03/31/1999EP0905139A2 5 ring heterocyles, process for preparation, use as inhibitors of leukocyte adhesion and pharmaceutical preparations comprising them
03/31/1999EP0904539A1 Inhibiting protein interactions
03/31/1999EP0904401A1 Combinatorial hydroxypropylamine library
03/31/1999EP0904294A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
03/31/1999EP0904284A1 6-substituted amino-4-oxa-1-azabicyclo (3,2,0) heptan-7-one derivatives as cysteine protease inhibitors
03/31/1999EP0904271A1 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES
03/31/1999EP0904095A1 Chimeric isoprenoid synthases and uses thereof
03/31/1999EP0750507A4 PROTEASOME REGULATION OF NF--g(k)B ACTIVITY
03/31/1999CN1212706A Serine protease inhibitors
03/31/1999CN1212705A Serine protease inhibitors
03/31/1999CN1212704A Serine protease inhibitors
03/30/1999US5889147 Bromo-tryptophan conopeptides
03/30/1999US5888992 Polar substituted hydrocarbons
03/30/1999US5888978 Method for reducing the severity of gastro-intestinal damage
03/30/1999US5888972 Endothelin antagonist
03/30/1999US5888971 Macrocyclic peptides useful in the treatment of thrombin related disorders
03/30/1999US5888969 Crohn*s disease
03/30/1999US5888512 Human leukocyte antigen peptides which can inhibit cytotoxic t-lymphocyte activity
03/30/1999US5888474 Technetium-99m labeled peptides for GPIIb/IIIa ligands useful for thrombus imaging
03/25/1999WO1999014231A2 Bifidus stimulating peptides and its uses
03/25/1999WO1999014186A1 Method of purifying and recovering sweetener
03/25/1999WO1999001470A3 Peptidomimetic derivatives suicidal inhibitors of the hiv proliferation
03/25/1999WO1999001103A3 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
03/25/1999WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors
03/25/1999WO1998051330A9 Method and compositions for treating hyperlipidemia and other conditions
03/24/1999EP0903353A1 Imidazolidine derivates, their preparation and use, and pharmaceutical compositions containing them
03/24/1999EP0903337A1 Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives
03/24/1999EP0664786B1 Arginine keto-amide enzyme inhibitors
03/24/1999CN1211991A Compounds with growth hormone releasing properties
03/24/1999CN1211990A Isoquinolines useful as analgesics
03/23/1999US5886156 A complex of tri or teterapeptide covalently linked to the peptide either directly or through a linker and lipid or mixture of lipids; useful in treatment of respiratory distress syndrome
03/23/1999US5886147 Compounds useful for the synthesis of dolastatin analogs
03/23/1999US5886146 Inhibitors of thrombosis
03/23/1999US5886036 Treating hiv infections